Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(13%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_1
5
63%
Ph phase_3
1
13%
Ph phase_2
2
25%

Phase Distribution

5

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
5(62.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(6)

Detailed Status

Completed6
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (62.5%)
Phase 22 (25.0%)
Phase 31 (12.5%)

Trials by Status

not_yet_recruiting113%
active_not_recruiting113%
completed675%

Recent Activity

1 active trials
Showing 5 of 8
not_yet_recruitingphase_2

Olorofim in Early Coccidioidal Meningitis

NCT07385638
active_not_recruitingphase_3

Olorofim Aspergillus Infection Study

NCT05101187
completedphase_2

Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

NCT03583164
completedphase_1

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment

NCT05200286
completedphase_1

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment

NCT04752540
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07385638Phase 2

Olorofim in Early Coccidioidal Meningitis

Not Yet Recruiting
NCT05101187Phase 3

Olorofim Aspergillus Infection Study

Active Not Recruiting
NCT03583164Phase 2

Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

Completed
NCT05200286Phase 1

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment

Completed
NCT04752540Phase 1

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment

Completed
NCT04207957Phase 1

A Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim

Completed
NCT04171739Phase 1

Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim

Completed
NCT04039880Phase 1

Absorption, Metabolism and Excretion of 14C-olorofim in Man

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8